Experimental models of coronary artery restenosis

Journal of the American College of Cardiology

Volumn 19, Issue 2, 1992, Pages 418-432

  Muller, David W M ^a   Ellis, Stephen G ^a   Topol, Eric J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOPEPTIN; ANTITHROMBOCYTIC AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CILAZAPRIL; COLCHICINE; CORTICOSTEROID; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; ENOXAPARIN; HEPARIN; HIRUDIN; LANTHANUM; MEVINOLIN; NIFEDIPINE; RESERPINE; TRAPIDIL; VERAPAMIL;

ANIMAL EXPERIMENT; BALLOON DILATATION; CORONARY ARTERY OBSTRUCTION; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; CALCIUM CHANNEL BLOCKERS; CONSTRICTION, PATHOLOGIC; CORONARY DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; HEPARIN; PLATELET AGGREGATION INHIBITORS; RECURRENCE; SPECIES SPECIFICITY;

EID: 0026502468     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(92)90500-M     Document Type: Review

References (175)

1. Percutaneous transluminal coronary angioplasty in 1985–1986 and 1977–1981
2. Coronary atherectomy: clinical, angiographic, and histological findings and observations regarding potential mechanisms
3. Advances in coronary angioplasty: endovascular stents
4. Percutaneous coronary excimer laser angioplasty in patients with stable and unstable angina pectoris: acute results and incidence of restenosis during 6 month follow-up
5. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia
6. Restenosis: the clinical issues
7. Morphologic analysis of 506 coronary athrectomy specimens from 107 patients historically similar findings of restenosis following primary balloon angioplasty versus primary atherectomy (abstr)
8. Restenosis tissue following hot tip laser, excimer laser, primary atherectomy and balloon angioplasty procedures: historically similar intimal proliferation in 33 atherectomy patients
9. Growth characteristics and cytoskeletal organisation of cultured smooth muscle cells from human primary stenosing and restenosing lesions
10. Primary peripheral arterial stenoses and restencses excised by transluminal atherectomy a histopathologic study
11. Restenosis after coronary angioplasty: new standards for clinical studies
12. Transluminal treatment of arteriosclerotic obstruction: description of a new technique and a preliminary report of its application
13. Transluminal dilatation of coronary artery stenosis
14. Transluminal angioplasty: correlation of morphological and angiographic findings in an experimental model
15. Transluminal coronary angioplasty of postmortem human hearts
16. Percutaneous transluminal angioplasty: radiological-pathological correlation
17. Morphology after transluminal angioplasty in human beings
18. Pathological findings after percutaneous transluminal coronary angioplasty
19. Coronary arterial findings after accidental death immediately after successful percutaneous transluminal coronary angioplasty
20. Early and late morphological changes in major epicardial coronary arteries after percutaneous transluminal coronary angioplasty
21. Effects of percutaneous transluminal coronary angioplasty on atherosclerotic plaques and relation of plaque composition and arterial size to outcome
22. Coronary luminal shape and the arc of disease-free wall: morphologic observations and clinical relevance
23. Transluminal coronary angioplasty and early restenosis: fibrocellular occlusion after wall laceration
24. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty
25. Status of the major coronary arteries 80 to 150 days percutaneous transluminal coronary angioplasty: analysis of 5 necropsy patients
26. Two distinct types of restenosis lesions after coronary balloon angioplasty: intimal proliferation and atherosclerotic plaques; an analysis of 20 necropsy patients (abstr)
27. Fibrocellular tissue response after percutaneous transluminal coronary angioplasty: an immunocytochemical analysis of the cellular composition
28. Early and late histological features after stenting of human saphenous vein bypass grafts (abstr)
29. Der atheromatous Prozess der Arteries
30. The pathogenesis of atherosclerosis—an update
31. Studies of hypercholesterolemia in the non-human primate: I. Changes that lead to fatty streak formation
32. Studies of hypercholesterolemia in the non-human primate: II. Fatty streak conversion to fibrous plaque
33. Dietary induced atherogenesis in swine: morphology of the intima in prelesion stages
34. The role of the monocyte in atherogenesis. I. Transition of blood borne monocytes into foam cells in fatty lesions
35. The role of the mononuclear phagocyte in primate and rabbit models of atherosclerosis
36. Fine structure of human aortic intimal thickening and fatty streaks
37. Persistent problems in the pathogenesis of atherosclerosis
38. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation
39. Hypothesis concerning membrane structure, cholesterol and atherosclerosis
40. Atheroarteriosclerosis induced for infection with a herpesvirus
41. Cytomegalovirus antigen within human arterial smooth muscle cells
42. Homocystinemia: vascular injury and arterial thrombosis
43. Accelerated coronary arterio-sclerosis in cardiac transplant recipients
44. Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations
45. Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet
46. The intima of human coronary arteries
47. A lamellar unit of aortic medial structure and function in mammals
48. Organogenesis of the arterial wall
49. A comparison of structural features of the walls of coronary arteries from 10 different species
50. Experimental models of human atherosclerosis
51. Animal models and the study of atherosclerosis
52. Obese spontaneously hypertensive rats: a model for the study of atherosclerosis
53. Development of atherosclerotic-like lesions in the sand rat (Psammomys obesus)
54. “Spontaneous” cardiovascular lesions in rats
55. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening
56. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat
57. Eine neue Methode zur Erzeugung der Thromben durch gezeille Uberdchnung der Gefasswand
58. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle cell growth in the absence of endothelium
59. Significance of quiescent smooth muscle migration in the injured rat carotid artery
60. Endothelial regeneration. II. Restitution of endothelial continuity
61. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle cell growth in chronically denuded vessels
62. Mechanisms of stenosis after arterial injury
63. Intimal lesion formation in rat caroid arteries after endothelial denudation in absence of medial injury
64. Endothelial regeneration. VII. Lack of intimal proliferation after defined injury to rat aorta
65. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries
66. The influence of the pituitary on arterial intimal proliferation in the rat
67. Hormonal requirements for growth of arterial smooth muscle cells in vitro: an endocrine approach to atherosclerosis
68. Aortic endothelial cell replication. I. Effects of age and hypertension in the rat
69. Arterial smooth muscle: a multifunctional mesenchymal cell
70. Vascular smooth muscle cell growth kinetics in vivo in aged rats
71. Spontaneous lesions of the aorta in the rabbit
72. Experimental arteriopathies in the rabbit (the devil's advocate)
73. Thromboatherosclerosis in normolipemic rabbits: a result of continued endothelial damage
74. Acute effects of transluminal angioplasty in three models of atherosclerosis
75. Cellular pathology of progressive atherosclerosis in the WHHL rabbit: an animal model of familial hypercholesterolemia
76. Transluminal angioplasty: correlation of morphologic and angiographic findings in an experimental model
77. Restenosis following transluminal angioplasty in experimental atherosclerosis
78. Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty: a study in the atherosclerotic rabbit
79. Atherosclerotic rabbit aortas: expandable intraluminal grafting
80. Steerable fiberoptic catheter delivery of laser energy in atherosclerotic rabbits
81. Rotational atherectomy in atherosclerotic rabbit iliac arteries
82. Immediate and long-term effects of angioplasty-balloon dilation on normal rabbit iliac artery
83. Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery
84. Experimental canine atherosclerosis
85. Interspecies healing of porous arterial prostheses: observations from 1960 to 1974
86. Impaired fibriolytic capacity and tissue plasminogen release in patients with restenosis after percutaneous transluminal coronary angioplasty (PTCA)
87. Proliferative and Epid metabolism response to balloon angioplasty in canine renal arteries
88. Acute and long-term effects of massive balloon dilation on the aortic wall and vasa vasorum
89. Endothelial denudation stimulates proliferation of vasa vasorum
90. Hypothesis: vasa vasorum and neovascularization of human coronary arteries
91. Freezing injury to large blood vessels in dogs
92. Balloon expandable itracoronary stents in the adult dog
93. Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs
94. Rotational endarterectomy in normal canine coronary arteries: preliminary report
95. Transluminal laser irradiation of coronary arteries in have dogs an angiographic and morphologic study of acute effects
96. A new model for investigation of transluminal recanalization human artherosclerotic coronary artery xenografts
97. Experimentally induced arteriosclerosis in nonhuman primates
98. Morphological studies on atherosclerosis in swine
99. The morphology and morphogenesis of atherosclerosis in aged swine
100. Experimental atherosclerosis of swine
101. Atherosclerosis in “miniature” swine
102. Yucatan miniature swine as a model for diet-induced atherosclerosis
103. Rapid production of advanced atherosclerosis in swine by a combination of endothelial injury and cholesterol feeding
104. Rapid production of advanced atherosclerosis in swine
105. Comparison of pathologic and angiographic findings in a porcine preparation of coronary atherosclerosis
106. Atherosclerotic Yucatan microswine: an animal model with high-grade, fibrocalcific, nonfatty lesions suitable for testing catheter-based interventions
107. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model
108. Effect of balloon inflation on smooth muscle cell proliferation in the porcine carotid artery (abstr)
109. Insights from quantitative histological analysis of excisional atherectomy specimens (abstr)
110. Coronary stenting with a new, radioopaque, balloon-expandable endoprosthesis in pigs
111. Restenosis after balloon angioplasty: a practical proliferative model in porcine coronary arteries
112. Comparison of the response to coronary artery balloon injury and stenting in swine: an animal model of restenosis (abstr)
113. Intracoronary stenting accelerates luminal narrowing in hypercholesterolemic swine (abstr)
114. Adjuvant therapy for intracoronary stents: investigations in atherosclerotic swine
115. Biology of disease: atherosclerosis as a hyperplastic and/or neoplastic process
116. Responses of cultured smooth muscle cells from human nonatatherosclerotic arteries and primary stenosing lesions after photoradiation: implications for photodynamic therapy of vascular stenoses
117. Effects of porcine aortic smooth muscle cell conditioned medium on endothelial cell replication
118. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells
119. Integrin receptors on aortic smooth muscle cells mediate adhesion to fibronectin, laminin, and collagen
120. Biological and biochemical properties of fibroblast growth factors: implications for the pathogenesis of atherosclerosis
121. Production of platelet-derived growth factor-like mitogen by smooth muscle cells from human atheroma
122. Platelet-derived growth factor
123. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty
124. Regulation of vascular smooth muscle cell growth by heparin and heparan sulphates
125. Heparin regulates smooth muscle cell S phase entry in the injured rat carotid artery
126. Suppression by heparin of smooth muscle cell proliferation in injured arteries
127. Inhibition of rat arterial smooth muscle cell proliferation by heparin: in vivo studies with anticoagulant and nonanticoagulant heparin
128. Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration
129. Effect of controlled adventtial heparin delivery on smooth muscle cell proliferation following endothelial injury
130. Low molecular weight heparin (enoxaparen) reduces restenosis after iliac angioplasty in the hyperchoiesterolemic rabbit
131. Effect of 18–24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty
132. Angiographic and pathologic study of the effect of recombinant desulphatohirudin on restenosis following balloon angioplasty in rabbits (abstr)
133. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits
134. Spontaneous and diet-induced coronary atherosclerosis in normal swine and swine with von Willebrand disease
135. Susceptibility to atherosclerosis in aortas and coronary arteries of swine with von Willebrand's disease
136. Effect of antiplatelet therapy on restenosis after experimental angioplasty
137. Failure of certain antiplatelet drugs to affect myontimal thickening following arterial endothelal injury in the rat
138. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty
139. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study
140. Inhibitory effect of calcium antagonists on balloon activatoc-induced arterial smooth muscle cell proliferation and lesion size
141. Inhibitors of angiostensin-converting enzyme prevent myointimal proliferation after vascular injury
142. Failure of nisoldipine to prevent restenosis after angioplasty in artherosclerotic rabbits (abstr)
143. Effect of nifedipine recurrent stenosis after percutaneous transluminal coronary angioplasty
144. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty
145. Prevention of restenosis by verapamil: the Verapamil Angioplasty Study (VAS) (abstr)
146. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiostensin II in cultured rat vascular smooth muscle cells
147. Angiotensin converting enzyme inhibition reduces restenosis in experimental angioplasty (abstr)
148. Can cilazapril reduce the developmenl of atheroselerotic changes in the balloon injured porcine carotid arteries? (abstr)
149. Effect of Cortisol on the proliferation and protein synthesis of human aortic smooth muscle cells in culture
150. The effect of cortison on the serum lipids and on the development on the experimental cholesterol atherosclerosis in the rabbit
151. Colchicine and antineoplastic therapy for the prevention of restenosis following percutaneous coronary interventions
152. Colchicine inhibits restenosis after coronary angioplasty (abstr)
153. Colchicine for the prevention of restenosis after coronary angioplasty (abstr)
154. A new approach to treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth facter
155. Suppression of fibroblast proliferation in vitro and of neointimal hyperplasia in vivo by the triazolopynmidine, trapidil
156. Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit
157. Trapidil (triazolopyrimidine), a platelet-derived growth factor (PDGF) antagonist in preventing restenosis after percutaneous transluminal coronary angioplasty (abstr)
158. Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034
159. Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide
160. Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor
161. Effects of mevinolin and mevalonate on cell growth in several transformed cell lines
162. The effect of lovostatin on intimal hyperplasia following balloon angioplasty: an angiographic and morphometric study of the femoral artery in the atherosclerotic rabbit (abstr)
163. Prevention of restenosis by lovastatin after successful coronary angioplasty
164. Adjuvant therapy for intracoronary stents: investigations in atherosclerotic swine
165. LaBlanche JM on behalf of the investigators of the TACT study. Results of a randomized trial of ticlopidine and placebo for prevention of acute closure and restenosis after coronary angioplasty (PTCA): the TACT study (abstr)
166. Cyclosporine inhibits the development of medial thickening after experimental arterial thickening
167. Effects of cyclosporin A on the injured artery wall: an in vivo and in-vitro study (abstr)
168. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate
169. Low dose of antitumor agents prevents smooth muscle cell proliferation after endothelial injury (abstr)
170. Intramural methotrexate therapy for the prevention of intimal proliferation following porcine carotid balloon angioplasty (abstr)
171. Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein
172. Effect of fish oil on atherogenesis in Watanabe heritable hyperlipidemic rabbit
173. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentanoic acid on the incidence of coronary restenosis after angioplasty
174. Reduction in the rate of early restonosis after coronary angioplasty by a diet supplemented with n-3 fatty acids